Work

Anti–IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels

Year: 2008

Type: article

Study design: Clinical Trial

Source: Journal of Allergy and Clinical Immunology

DOI: 10.1016/j.jaci.2008.02.033

Authors: Miguel L. Stein, Joyce M. Villanueva, Bridget K. Buckmeier, Yoshiyuki Yamada, Alexandra H. Filipovich, Amal H. Assa'ad, Marc E. Rothenberg

Institutions: Cincinnati Children's Hospital Medical Center, University of Cincinnati

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Food and Drug Administration, National Center for Research Resources

Awards: General Clinical Research Center, G1794108063

OpenAlex ID: W1974262000

FWCI: 6.817

Cites: 35

Cited by: 144

Related to: 10